Deliver to Japan
For best experience Get the App
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Trustpilot
Suresh K.
4 days ago
Ali H.
1 day ago
Abdullah B.
3 weeks ago
Zainab N.
1 week ago
